BCAB Logo

BioAtla, Inc. (BCAB) 

NASDAQ
Market Cap
$31.17M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
566 of 954
Rank in Industry
308 of 546

Largest Insider Buys in Sector

BCAB Stock Price History Chart

BCAB Stock Performance

About BioAtla, Inc.

BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and ovarian cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.

Insider Activity of BioAtla, Inc.

Over the last 12 months, insiders at BioAtla, Inc. have bought $0 and sold $0 worth of BioAtla, Inc. stock.

On average, over the past 5 years, insiders at BioAtla, Inc. have bought $26.51M and sold $101.07M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 4,000 shares for transaction amount of $9,320 was made by MCBRINN SYLVIA (director) on 2023‑12‑26.

List of Insider Buy and Sell Transactions, BioAtla, Inc.

2023-12-26Purchasedirector
4,000
0.0082%
$2.33$9,320-13.87%
2023-12-20PurchaseChief Executive Officer
50,000
0.1107%
$2.14$106,910+1.47%
2023-12-19PurchaseSee Remarks
7,495
0.0159%
$2.04$15,262+3.04%
2023-12-19Purchasedirector
20,000
0.0427%
$2.05$41,048+3.04%
2023-09-08Purchasedirector
2,000
0.0044%
$2.54$5,080-17.05%
2023-03-29PurchaseChief Executive Officer
40,800
0.0845%
$2.47$100,862+1.79%
2023-03-28PurchaseSee Remarks
20,000
0.0429%
$2.40$47,970+8.51%
2023-03-28Purchasedirector
4,000
0.0084%
$2.35$9,400+8.51%
2022-12-19Purchasedirector
3,700
0.0097%
$8.33$30,813-64.47%
2022-11-22Purchasedirector
2,000
0.0048%
$8.27$16,540-66.02%
2022-08-12PurchaseChief Executive Officer
26,350
0.0788%
$7.84$206,600-46.78%
2022-06-21PurchaseChief Executive Officer
40,308
0.114%
$2.91$117,296+40.73%
2022-06-07PurchaseSee Remarks
10,000
0.0258%
$2.97$29,720+25.65%
2021-12-02SaleChief Executive Officer
4,811
0.0135%
$21.76$104,666-70.68%
2021-12-02SalePresident
2,984
0.0084%
$21.76$64,918-70.68%
2021-12-02SaleChief Financial Officer
1,434
0.004%
$21.76$31,198-70.68%
2021-12-02SaleChief Medical Officer
820
0.0023%
$21.76$17,839-70.68%
2021-12-02SaleSee Remarks
200
0.0006%
$21.76$4,351-70.68%
2021-12-01SaleChief Executive Officer
24,321
0.0763%
$23.03$560,226-69.08%
2021-12-01SalePresident
628
0.002%
$23.03$14,466-69.08%

Insider Historical Profitability

<0.0001%
Cormorant Asset Management, LP
2292060
3.9501%
$0.5410+17.46%
SHORT JAY M PHDChief Executive Officer
1439283
2.4805%
$0.54413<0.0001%
Smith Scott AndrewPresident
345656
0.5957%
$0.5409
Levy Guydirector
217358
0.3746%
$0.5412+17.46%
WALDRON RICHARD AChief Financial Officer
134469
0.2317%
$0.5407
Vasquez ChristianSee Remarks
115659
0.1993%
$0.5437+17.08%
Sievers EricChief Medical Officer
91506
0.1577%
$0.5409
STEINMAN LAWRENCEdirector
38459
0.0663%
$0.5414
MCBRINN SYLVIAdirector
15125
0.0261%
$0.5450<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Soleus Capital Management, L.P.$13.98M8.454.07M0%+$00.06
BlackRock$9.56M5.782.78M-3.62%-$358,836.70<0.0001
The Vanguard Group$7.22M4.362.1M+0.85%+$60,774.48<0.0001
Morgan Stanley$6.57M3.971.91M-0.15%-$10,220.24<0.0001
Tang Capital Management, LLC$5.07M3.061.47M-41.6%-$3.61M0.02
Deutsche Bank$4.28M2.591.24M+10.58%+$409,511.39<0.01
Cormorant Asset Management Lp$4.03M2.431.17M-0.87%-$35,242.800.19
Renaissance Technologies$3.43M2.07996,300+0.89%+$30,269.600.01
Geode Capital Management$3.18M1.92922,938+2.09%+$64,878.64<0.0001
Millennium Management LLC$3.01M1.82873,654+299.29%+$2.25M<0.01
State Street$2.72M1.65791,278+9.24%+$230,166.93<0.0001
Boxer Capital, LLC$2.36M1.43686,3470%+$00.05
Massachusetts Financial Services Co Ma$1.81M1.09526,462-0.51%-$9,267.36<0.01
Healthcare Of Ontario Pension Plan Trust Fund$1.76M1.07512,3000%+$00.01
Northern Trust$1.22M0.74353,940-0.55%-$6,721.76<0.0001
MAI Capital Management, LLC$1.14M0.69330,395New+$1.14M0.01
Two Sigma Advisers LP$1.03M0.62299,700+14.87%+$133,472.00<0.01
Bank of Montreal$907,156.000.54260,677-13.29%-$139,001.65<0.0001
Dimensional Fund Advisors$895,294.000.54260,260+23.49%+$170,286.80<0.0001
Connor Clark & Lunn Investment Management Ltd$804,743.000.49233,937+74.36%+$343,212.12<0.01
Ubs Oconnor Llc$721,609.000.44209,770+16.27%+$100,953.710.03
Two Sigma$698,626.000.42203,089+18.85%+$110,826.46<0.01
Myda Advisors Llc$619,200.000.37180,000-18.18%-$137,600.000.12
Nuveen$611,811.000.37177,8520%+$0<0.0001
Xtx Topco Ltd$565,422.000.34164,367New+$565,422.000.01
Acadian Asset Management$532,000.000.32155,188+57.65%+$194,537.83<0.01
Toroso Investments Llc$502,302.000.3145,174-5.88%-$31,389.12<0.01
Formidable Asset Management LLC$499,399.000.3145,174-5.88%-$31,207.710.09
Woodline Partners LP$458,256.000.28133,214New+$458,256.00<0.01
BNY Mellon$421,455.000.26122,516-7.88%-$36,078.72<0.0001
Charles Schwab$411,249.000.25119,5490%+$0<0.0001
Bridgeway Capital Management$309,600.000.1990,000-10%-$34,400.00<0.01
Susquehanna International Group$306,790.000.1989,183+50.32%+$102,697.92<0.0001
Panagora$306,408.000.1989,072-20.02%-$76,691.44<0.01
Chase Investment Counsel Corp$263,000.000.1676,742New+$263,000.000.1
Manatuck Hill Partners LLC$258,000.000.1675,000New+$258,000.000.05
Citadel Advisors LLC$249,871.000.1572,637-0.69%-$1,747.52<0.0001
Sc H Financial Advisors Inc$225,385.000.1465,5190%+$00.1
RhumbLine Advisers$216,005.000.1362,795+3.47%+$7,251.19<0.0001
Cornercap Investment Counsel Inc$210,528.000.1361,2000%+$00.03
Goldman Sachs$162,313.000.147,184+21.76%+$29,009.53<0.0001
UBS$162,805.000.147,327-0.97%-$1,596.16<0.0001
Simplex Trading Llc$148,000.000.0943,239+262.56%+$107,179.26<0.01
American Century Investments$109,695.000.0731,888New+$109,695.00<0.0001
Kennedy Capital Management Inc$108,044.000.0731,408+6.39%+$6,487.87<0.01
Barclays$107,000.000.0731,202-48.76%-$101,818.38<0.0001
JPMorgan Chase$105,136.000.0630,563-21.59%-$28,954.28<0.0001
Virtu Financial Llc$103,000.000.0630,012New+$103,000.000.01
New York State Common Retirement Fund$94,000.000.0627,260-0.16%-$148.28<0.0001
American International Group$74,989.000.0521,799-0.85%-$643.28<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.